Side population cells of common tumor

doi:10.3760/cma.j.issn.1673422X.2014.11.001

Abstract

ZHU Chao, QIAN Jun. Side population cells of common tumor[J]. Journal of International Oncology, 2014, 41(11): 801-804.

［1］ Xiang W, Shi JF, Li P, et al. Estimation of cancer cases and deaths attributable to infection in China［J］. Cancer Causes Control， 2011, 22(8):11531161. ［2］ Garvalov BK, Acker T. Cancer stem cells:a new framework for the design of tumor therapies ［J］. J Mol Med， 2011, 89(2):95107. ［3］ Valent P, Bonnet D, De Maria R, et al. Cancer stem cells definitions and terminology:the devil is in thedetails［J］. Cancer， 2012， 11(12):767775. ［4］ Shackleton M. Normal stem cells and cancer stem cells:similar and different［J］. Semin Cancer Biol， 2010, 20(2):8592. ［5］ Deonarain MP, Kousparou CA, Epenetos AA. Antibodies targeting cancer stem cells:a new paradigm in immunotherapy［J］.MAbs， 2009, 1(1):1225. ［6］ Hittelman WN, Liao Y, Wang L, et al. Are cancer stem cells radioresistant［J］. Future Oncol， 2010, 6(10):15631576. ［7］ Fong D, Yeh A, Naftalovich R, et al. Curcumin inhibits the side population (SP) phenotype of the rat C6 glioma cell line:towards targeting of cancer stem cells with phytochemicals［J］. Cancer Lett， 2010, 293(1):6572. ［8］ Lan L, Cui D, Nowka K, et al． Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require thyrotropin for differentiation into thyrocytes［J］. J Clin Endocrinol Metab， 2007, 92(9):36813688. ［9］ Todaro M, Iovino F, Eterno V, et al. Tumorigenic and metastatic activity of human thyroid cancer stem cells［J］. Cancer Res， 2010, 70(21):88748885. ［10］ Mitsutake N, Iwao A, Nagai K, et al. Characterization of side population in thyroid cancer cell lines cancer stem like cells are enriched partly but not exclusively ［J］. Endocrinology， 2007, 148(4):17971803. ［11］张菀姣, 兰玲, 郑旭琴, 等. 甲状腺癌中类干细胞的侧群细胞的分离及鉴定［J］.南京医科大学学报， 2012, 32(5):585591. ［12］黄哲宙, 陈万青, 吴春晓, 等. 中国女性乳腺癌的发病和死亡现况——全国32个肿瘤登记点 2003—2007年资料分析报告［J］. 肿瘤， 2012, 23(6):435439. ［13］ Xu W, Lin H, Zhang Y, et al. Compound Kushen Injection suppresses human breast cancer stemlike cells by down regulating the canonical Wnt/catenin pathway［J］. J Exp Clin Cancer Res， 2011, 30:103. ［14］ Nakanishi T, Chumsri S, Khakpour N, et al. Side population cells in luminal type breast cancer have tumourinitiating cell properties,and are regulated by HER2 expression and signaling［J］. Br J Cancer， 2010, 102( 5):815826. ［15］杨晓宁, 周艳, 齐晓伟, 等. 成骨细胞诱导乳腺癌侧群细胞获得骨模拟特性的研究［J］. 第三军医大学学报， 2013, 35(11):11021106. ［16］孙欣, 樊翀, 胡丽娟, 等. Let7维持乳腺癌干细胞的特性及机制的研究［J］. 细胞与分子免疫学杂志， 2012, 28(8):789792. ［17］ Jemal A, Bray F, Center MM, et al. Global cancer statistics［J］. CA Cancer J Clin， 2011, 61(2):6990. ［18］ Li H, Gao Q, Guo L, et al. The PTEN/PI3K/Akt pathway regulates stemlike cells in primary esophageal carcinoma cells［J］. Cancer Biol Ther， 2011, 11(11)：950958. ［19］ Yu X, Jiang X, Li H, et al. miR203 Inhibits the proliferation and selfrenewal of esophageal cancer stemlike cells by suppressing stem renewal factor Bmi1［J］. Stem Cells Dev， 2014, 23(6):576585. ［20］ Siegel R, Ma J, Zou Z, et al. Cancer statistics,2014［J］. CA Cancer J Clin， 2014, 64(1):929. ［21］ Singh S, Trevino J, BoraSinghal N, et al. EGFR/Src/Akt signaling modulates Sox2 expression and selfrenewal of stemlike sidepopulation cells in nonsmall cell lung cancer［J］. Mol Cancer， 2012, 11:73. ［22］ Hua S, Xiaotao X, Renhua G, et al. Reduced miR31 and let7 maintain the balance between differentiation and quiescence in lung cancer stemlike side population cells［J］.Biomed Pharmacother， 2012,66(2):8997. ［23］ Hayashi S, Fujita K, Matsumoto S, et al. Isolation and identification of cancer stem cells from a side population of a human hepatoblastoma cell line, HuH6 clone5［J］. Pediatr Surg Int， 2011, 27(1):916. ［24］ Zhai JM, Yin XY, Hou X, et al. Analysis of the genomewide DNA methylation profile of side population cells in hepatocellular carcinoma［J］. Dig Dis Sci， 2013, 58(7):19341947. ［25］ Meyer HJ, Wilke H. Gastric cancer:current status of multimodalitytreatment［J］. Zentralbl Chir， 2011, 136(4):317324. ［26］ Dikken JL, van de Velde CJ, Coit DG, et al. Treatment of resectable gastric cancer［J］. Therap Adv Gastroenterol， 2012, 5(1):4969. ［27］ Zhang HH, Cai AZ, Wei XM, et al. Characterization of cancer stemlike cells in the side population cells of human gastric cancer cell line MKN45［J］. J Zhejiang Univ Sci B， 2013, 14(3):216223. ［28］ Li R, Wu X, Wei H, et al. Characterization of side population cells isolated from the gastric cancer cell line SGC7901［J］.Oncol Lett， 2013, 5(3):877883. ［29］ Hasegawa T, Yashiro M, Nishii T, et al. Cancerassociated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factorβ signaling［J］. Int J Cancer， 2014, 134(8):17851795. ［30］ López J, Poitevin A, MendozaMartínez V, et al. Cancerinitiating cells derived from eslablished cervical cell lines exhibit stemcell markers and increased radioresistance［J］. BMC Cancer， 2012, 12:48. ［31］ Shishido Y, Ueno S, Yamazaki R, et al. ABCG2 inhibitor YHO13351 sensitizes cancer stem/initiatinglike side population cells to irinotecan［J］. Anticancer Res， 2013, 33(4):13791386. ［32］ Qi W, Zhao C, Zhao L, et al. Sorting and identification of side population cells in the human cervical cancer cell line HeLa［J］. Cancer Cell Int， 2014, 14(1):3.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou. Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer [J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Yang Mi, Bie Jun, Zhang Jiayong, Deng Jiaxiu, Tang Zuge, Lu Jun. Analysis of the efficacy and prognosis of neoadjuvant therapy for locally advanced resectable esophageal cancer [J]. Journal of International Oncology, 2024, 51(6): 332-337.
[3]	Yuan Jian, Huang Yanhua. Diagnostic value of Hp-IgG antibody combined with serum DKK1 and sB7-H3 in early gastric cancer [J]. Journal of International Oncology, 2024, 51(6): 338-343.
[4]	Chen Hongjian, Zhang Suqing. Study on the relationship between serum miR-24-3p， H2AFX and clinical pathological features and postoperative recurrence in liver cancer patients [J]. Journal of International Oncology, 2024, 51(6): 344-349.
[5]	Guo Zehao, Zhang Junwang. Role of PFDN and its subunits in tumorigenesis and tumor development [J]. Journal of International Oncology, 2024, 51(6): 350-353.
[6]	Zhang Baihong, Yue Hongyun. Advances in anti-tumor drugs with new mechanisms of action [J]. Journal of International Oncology, 2024, 51(6): 354-358.
[7]	Xu Fenglin, Wu Gang. Research progress of EBV in tumor immune microenvironment and immunotherapy of nasopharyngeal carcinoma [J]. Journal of International Oncology, 2024, 51(6): 359-363.
[8]	Wang Ying, Liu Nan, Guo Bing. Advances of antibody-drug conjugate in the therapy of metastatic breast cancer [J]. Journal of International Oncology, 2024, 51(6): 364-369.
[9]	Zhang Rui, Chu Yanliu. Research progress of colorectal cancer risk assessment models based on FIT and gut microbiota [J]. Journal of International Oncology, 2024, 51(6): 370-375.
[10]	Gao Fan, Wang Ping, Du Chao, Chu Yanliu. Research progress on intestinal flora and non-surgical treatment of the colorectal cancer [J]. Journal of International Oncology, 2024, 51(6): 376-381.
[11]	Liu Jing, Liu Qin, Huang Mei. Prognostic model construction of lung infection in patients with chemoradiotherapy for esophageal cancer based on SMOTE algorithm [J]. Journal of International Oncology, 2024, 51(5): 267-273.
[12]	Yang Lin, Lu Ning, Wen Hua, Zhang Mingxin, Zhu Lin. Study on the clinical relationship between inflammatory burden index and gastric cancer [J]. Journal of International Oncology, 2024, 51(5): 274-279.
[13]	Wang Junyi, Hong Kaibin, Ji Rongjia, Chen Dachao. Effect of cancer nodules on liver metastases after radical resection of colorectal cancer [J]. Journal of International Oncology, 2024, 51(5): 280-285.
[14]	Zhang Ningning, Yang Zhe, Tan Limei, Li Zhenning, Wang Di, Wei Yongzhi. Diagnostic value of cervical cell DNA ploidy analysis combined with B7-H4 and PKCδ for cervical cancer [J]. Journal of International Oncology, 2024, 51(5): 286-291.
[15]	Fu Yi, Ma Chenying, Zhang Lu, Zhou Juying. Research progress of habitat analysis in radiomics of malignant tumors [J]. Journal of International Oncology, 2024, 51(5): 292-297.

Side population cells of common tumor

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments